Brean Murray Carret & Co. is reaffirming its Sell rating on shares of Auxilium Pharmaceuticals (NASDAQ: AUXL) and is reducing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE